Ecolab (ECL) Stock Forecast & Price Target

Ecolab is well positioned for sustained outperformance because its 90%+ recurring-revenue model, dominant share in a $152bn addressable market, and broad “One Ecolab” cross-selling platform support durable demand and rising wallet share across Water, Institutional & Specialty, Pest, Life Sciences, and digital solutions. Growth should accelerate as pricing surcharges and structural price increases offset about 8-9% commodity inflation in 2Q26 and ~9% in 2H26, while margin expansion toward 19% in FY26 is aided by lower commodity costs, SG&A leverage, and $325m of structural synergies. The outlook is further strengthened by higher-growth engines such as High-Tech, which should approach ~$1.5bn of annualized revenue after CoolIT and Ovivo, Life Sciences at 10-12% organic growth, and Pest Elimination improving to 7-8%, all of which reinforce double-digit EPS potential over the mid-term.

Ecolab is viewed negatively because its near-term operating momentum appears uneven, with 1% volume growth in 1Q26 followed by expected 2Q26 headwinds from the war in Iran and lingering weakness in Paper and Heavy Industries. Although management is modeling ~55 bps of FY26 margin expansion to ~18.5% aided by pricing, mix, and the One Ecolab program’s $325m savings target by FY27, that improvement is partly offset by cost-transition pressure in 2Q26 and commodity volatility. The stock also faces elevated execution and valuation risk, since any slowdown in growth or market share gains could compress FY27E EPS by about 10% in the downside case.